{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:25:46Z","timestamp":1792707946430,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["331065168"],"award-info":[{"award-number":["331065168"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BA622\/2\u20131"],"award-info":[{"award-number":["BA622\/2\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2375"],"award-info":[{"award-number":["GRK2375"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LA-2937\/4\u20131"],"award-info":[{"award-number":["LA-2937\/4\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1066"],"award-info":[{"award-number":["SFB1066"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU21\u201308-00280"],"award-info":[{"award-number":["NU21\u201308-00280"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2018.129.1"],"award-info":[{"award-number":["2018.129.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"ERC","doi-asserted-by":"publisher","award":["864121"],"award-info":[{"award-number":["864121"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jconrel.2023.11.044","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T03:50:17Z","timestamp":1701316217000},"page":"358-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy"],"prefix":"10.1016","volume":"365","author":[{"given":"Diana","family":"M\u00f6ckel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bartneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Niemietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Ehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Gremse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Eulberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Pechar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Etrych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kiessling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Twan","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2023.11.044_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2014.12.009","article-title":"Vascular-promoting therapy reduced tumor growth and progression by improving chemotherapy efficacy","volume":"27","author":"Bridges","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2023.11.044_bb0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fonc.2013.00154","article-title":"The tumor microenvironment and strategies to improve drug distribution","volume":"3","author":"Saggar","year":"2013","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2023.11.044_bb0015","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.copbio.2013.02.020","article-title":"Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications","volume":"24","author":"Rizzo","year":"2013","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.11.044_bb0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","article-title":"Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress","volume":"161","author":"Lammers","year":"2012","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2023.11.044_bb0025","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/jpm11080771","article-title":"The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jconrel.2023.11.044_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2023.11.044_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2012.10.002","article-title":"The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo","volume":"65","author":"Maeda","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.jconrel.2023.11.044_bb0040","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","article-title":"Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia","volume":"26","author":"Jain","year":"2014","journal-title":"Cancer Cell"},{"issue":"47","key":"10.1016\/j.jconrel.2023.11.044_bb0045","doi-asserted-by":"crossref","first-page":"19059","DOI":"10.1073\/pnas.1318022110","article-title":"Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation","volume":"110","author":"Batchelor","year":"2013","journal-title":"PNAS."},{"issue":"3","key":"10.1016\/j.jconrel.2023.11.044_bb0050","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases","volume":"91","author":"Goel","year":"2011","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.jconrel.2023.11.044_bb0055","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.jconrel.2023.11.044_bb0060","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.jconrel.2023.11.044_bb0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.1027","volume":"196","author":"Bingle","year":"2002","journal-title":"J. Pathol."},{"issue":"12","key":"10.1016\/j.jconrel.2023.11.044_bb0070","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1136\/gutjnl-2013-306294","article-title":"CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis","volume":"63","author":"Ehling","year":"2014","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.jconrel.2023.11.044_bb0075","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2444","article-title":"The role of myeloid cells in the promotion of tumuor angiogenesis","volume":"8","author":"Murdoch","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.jconrel.2023.11.044_bb0080","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10555-006-9027-x","article-title":"CCL2 (monocyte chemoattractant protein-1) in cancer bone metastases","volume":"25","author":"Craig","year":"2006","journal-title":"Cancer Metastasis Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2023.11.044_bb0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jcmgh.2018.10.007","article-title":"The CCR2+ macrophages subset promotes pathogenic angiogenesis for tumor vascularization in fibrotic livers","volume":"7","author":"Bartneck","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2023.11.044_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-407704-1.00001-4","article-title":"Role of macrophage polarization in tumor angiogenesis and vessel normalization: implications for new anticancer therapies","volume":"301","author":"Chen","year":"2013","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"7355","key":"10.1016\/j.jconrel.2023.11.044_bb0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.11.044_bb0100","series-title":"A Phase Ila Study to Characterize the effects of CCL2 Inhibition with the Spiegelmer NOX-E36 in Patients with Type 2 Diabetes Mellitus and Albuminuria","author":"Clinical Trial","year":"2012"},{"issue":"1","key":"10.1016\/j.jconrel.2023.11.044_bb0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drudis.2014.09.004","article-title":"Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer therapeutics","volume":"20","author":"Vater","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.jconrel.2023.11.044_bb0110","first-page":"3269","article-title":"Bioactive nanotherapeutic trends to combat triple negative breast cancer","volume":"6","author":"Chowdhury","year":"2021","journal-title":"Bioact. Mater."},{"issue":"11","key":"10.1016\/j.jconrel.2023.11.044_bb0115","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Giampaolo","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.11.044_bb0120","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/s41467-018-03973-8","article-title":"Motion model ultrasound localization microscopy for preclinical and clinical multiparametric tumor characterization","volume":"9","author":"Opacic","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.11.044_bb0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2018.05.002","article-title":"Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors","volume":"282","author":"Theek","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.11.044_bb0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.02.021","article-title":"Sonoporation enhances liposome accumulation and penetration in tumors with low EPR","volume":"231","author":"Theek","year":"2016","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2023.11.044_bb0135","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.7150\/thno.41161","article-title":"Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation","volume":"10","author":"May","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.11.044_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6591-5_2","article-title":"Thin-film hydration followed by extrusion method for liposome preparation","volume":"1522","author":"Zhang","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2023.11.044_bb0145","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7150\/thno.13624","article-title":"Imalytics preclinical: interactive analysis of biomedical volume data","volume":"6","author":"Gremse","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.11.044_bb0150","first-page":"e52770","article-title":"Hybrid \u03bcCT-FMT imaging and image analysis","volume":"100","author":"Gremse","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"10","key":"10.1016\/j.jconrel.2023.11.044_bb0155","doi-asserted-by":"crossref","first-page":"960","DOI":"10.7150\/thno.9293","article-title":"Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography","volume":"4","author":"Gremse","year":"2014","journal-title":"Theranostics."},{"issue":"1","key":"10.1016\/j.jconrel.2023.11.044_bb0160","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/nn303955n","article-title":"Noninvasive optical imaging of nanomedicine biodistribution","volume":"7","author":"Kunjachan","year":"2013","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2023.11.044_bb0165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ajpath.2013.10.014","article-title":"Micro-CT imaging of tumor angiogenesis: quantitative measures describing micromorphology and vascularization","volume":"184","author":"Ehling","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2023.11.044_bb0170","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/CIRCIMAGING.113.000805","article-title":"Rhodamine-loaded intercellular adhesion molecule\u20131-targeted microbubbles for dual-modality imaging under controlled shear stresses","volume":"6","author":"Wu","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"5","key":"10.1016\/j.jconrel.2023.11.044_bb0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Sica","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2023.11.044_bb0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fonc.2019.00421","article-title":"Macrophage polarization in the development and progression of ovarian cancers: an overview","volume":"9","author":"Cheng","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.11.044_bb0185","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12935-021-02089-2","article-title":"New insights into M1\/M2 macrophages: key modulators in cancer progression","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"14","key":"10.1016\/j.jconrel.2023.11.044_bb0190","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-09-4672","article-title":"Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes","volume":"70","author":"Movahedi","year":"2010","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.jconrel.2023.11.044_bb0195","first-page":"75","article-title":"Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis","volume":"5","author":"Riabov","year":"2014","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.jconrel.2023.11.044_bb0200","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.7150\/thno.71443","article-title":"Super-stable cyanine@albumin fluorophore for enhanced NIR-II bioimaging","volume":"12","author":"Bai","year":"2022","journal-title":"Theranostics."},{"issue":"2","key":"10.1016\/j.jconrel.2023.11.044_bb0205","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.biomaterials.2013.10.033","article-title":"Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent","volume":"35","author":"Zheng","year":"2014","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2023.11.044_bb0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","article-title":"Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies","volume":"2","author":"Chauhan","year":"2011","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"issue":"10","key":"10.1016\/j.jconrel.2023.11.044_bb0215","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1158\/0008-5472.CAN-12-4354","article-title":"Vascular normalization as an emerging strategy to enhance cancer immunotherapy","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.jconrel.2023.11.044_bb0220","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nnano.2012.45","article-title":"Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner","volume":"7","author":"Chauhan","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.jconrel.2023.11.044_bb0225","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.3390\/biomedicines10092292","article-title":"The interplay of tumor vessels and immune cells affects immunotherapy of glioblastoma","volume":"10","author":"Ghosh","year":"2022","journal-title":"Biomedicines."},{"issue":"3","key":"10.1016\/j.jconrel.2023.11.044_bb0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jconrel.2023.11.044_bb0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2019.12.018","article-title":"Tumor immunology and tumor evolution: intertwined histories","volume":"52","author":"Galon","year":"2020","journal-title":"Immunity."},{"key":"10.1016\/j.jconrel.2023.11.044_bb0240","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1158\/1078-0432.CCR-15-2338","article-title":"Tumor-infiltrating lymphocytes: a predictive and prognostic biomarker in neoadjuvant-treated HER2-positive breast cancer","volume":"22","author":"Heppner","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.11.044_bb0245","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12916-015-0431-3","article-title":"Relevance of tumor-infiltrating lymphocytes in breast cancer","volume":"13","author":"Dushyanthen","year":"2015","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.jconrel.2023.11.044_bb0250","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s42003-020-01441-y","article-title":"Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy","volume":"3","author":"Tu","year":"2020","journal-title":"Commun. Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2023.11.044_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2019.12.010","article-title":"Resistance to checkpoint inhibition in cancer immunotherapy","volume":"13","author":"Barrueto","year":"2020","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.11.044_bb0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jconrel.2023.11.044_bb0265","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/ijc.24859","article-title":"Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma","volume":"126","author":"Abraham","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"46","key":"10.1016\/j.jconrel.2023.11.044_bb0270","first-page":"18632","article-title":"Combining two strategies to improve perfusion and drug delivery in solid tumors","volume":"110","author":"Stylianopoulos","year":"2013"},{"issue":"4","key":"10.1016\/j.jconrel.2023.11.044_bb0275","first-page":"292","article-title":"Reengineering the physical microenvironment of tumors to improve drug delivery and efficacy: from mathematical modeling to bench to bedside","volume":"4","author":"Stylianopoulos","year":"2018"},{"issue":"8","key":"10.1016\/j.jconrel.2023.11.044_bb0280","doi-asserted-by":"crossref","first-page":"905","DOI":"10.7150\/thno.11304","article-title":"Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusion","volume":"5","author":"Doleschel","year":"2015","journal-title":"Theranostics."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923007617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923007617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:50:44Z","timestamp":1759164644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923007617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":56,"alternative-id":["S0168365923007617"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.11.044","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.11.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}